Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 2 (2005), Issue 3 (March)

1. Reliability of automated blood pressure devices used by hypertensive patients.
   J R Soc Med, 98(3): 111-3. [Abstract] [Full-text]
2. Late first-trimester placental disruption and subsequent gestational hypertension/preeclampsia.
   Obstet Gynecol, 105(3): 587-92. [Abstract] [Full-text]
3. Longitudinal left ventricular myocardial dysfunction assessed by 2D colour tissue Doppler imaging in a dog with systemic hypertension and severe arteriosclerosis.
   J Vet Med A Physiol Pathol Clin Med, 52(2): 83-7. [Abstract] [Full-text]
4. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.
   Circulation, 111(8): 1012-8. [Abstract] [Full-text]
5. High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats.
   Circulation, 111(8): 1006-11. [Abstract] [Full-text]
6. Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension.
   Biomed Pharmacother, 59(1): 25-9. [Abstract] [Full-text]
7. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy.
   Biomed Pharmacother, 59(1): 15-9. [Abstract] [Full-text]
8. Hypertension, antihypertensive agents and outcomes following renal transplantation.
   Clin Transplant, 19(2): 181-92. [Abstract] [Full-text]
9. Is measurement of blood pressure worthwhile in the diabetic eye clinic?
   Eye, 19(3): 312-6. [Abstract] [Full-text]
10. Experimental and clinical study of the combined effect of arterial stiffness and heart rate on pulse pressure: differences between central and peripheral arteries.
    Clin Exp Pharmacol Physiol, 32(3): 210-7. [Abstract] [Full-text]
11. Effects of uninephrectomy on renal structural properties in spontaneously hypertensive rats.
    Clin Exp Pharmacol Physiol, 32(3): 173-8. [Abstract] [Full-text]
12. Low adherence with antihypertensives in actual practice: the association with social participation--a multilevel analysis.
    BMC Public Health, 5(1): 17. [Abstract] [Full-text]
13. Antihypertensive effects of flutamide in rats that are exposed to a low-protein diet in utero.
    Am J Obstet Gynecol, 192(3): 952-60. [Abstract] [Full-text]
14. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Am J Obstet Gynecol, 192(3): 734-41. [Abstract] [Full-text]
15. The association of plasma adiponectin levels with hypertensive retinopathy.
    Eur J Endocrinol, 152(2): 233-40. [Abstract] [Full-text]
16. The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.
    J Diabetes Complications, 19(2): 74-9. [Abstract] [Full-text]
17. A diagnostic approach for the child with hypertension.
    Pediatr Nephrol, 20(4): 499-506. [Abstract] [Full-text]
18. 24-hour ambulatory blood pressure monitoring in children with familial dysautonomia.
    Pediatr Nephrol, 20(4): 507-11. [Abstract] [Full-text]
19. Changes of blood pressure and left ventricular mass in pediatric renal transplantation.
    Pediatr Nephrol, 19(12): 1385-9. [Abstract] [Full-text]
20. Body mass index in primary and secondary pediatric hypertension.
    Pediatr Nephrol, 19(12): 1379-84. [Abstract] [Full-text]
21. Low nephron number--a new cardiovascular risk factor in children?
    Pediatr Nephrol, 19(12): 1319-23. [Abstract] [Full-text]
22. A study of lipoprotein lipase gene intron 8 polymorphisms in Chinese Han race essential hypertension patients.
    Int J Cardiol, 99(2): 263-7. [Abstract] [Full-text]
23. Sympatho-renal interactions in the determination of arterial pressure: role in hypertension.
    Exp Physiol, 90(2): 183-7. [Abstract] [Full-text]
24. An infrarenal abdominal aortic coarctation.
    Surg Radiol Anat, 27(1): 71-3. [Abstract] [Full-text]
25. Mast cell chymase in the ischemic kidney of severe unilateral renovascular hypertension.
    Am J Kidney Dis, 45(3): e45-50. [Abstract] [Full-text]
26. Antihypertensive drug interactions.
    Drugs Today (Barc), 41(1): 55-63. [Abstract] [Full-text]
27. Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals.
    Am J Hypertens, 18(2): 287-94. [Abstract] [Full-text]
28. Impact of a social marketing media campaign on public awareness of hypertension.
    Am J Hypertens, 18(2): 270-5. [Abstract] [Full-text]
29. Low mineral intake is associated with high systolic blood pressure in the Third and Fourth National Health and Nutrition Examination Surveys: could we all be right?
    Am J Hypertens, 18(2): 261-9. [Abstract] [Full-text]
30. What is the accuracy of clinic blood pressure measurement?
    Am J Hypertens, 18(2): 244-8. [Abstract] [Full-text]
31. The effect of rosiglitazone on urine albumin excretion in patients with type 2 diabetes mellitus and hypertension.
    Am J Hypertens, 18(2): 227-34. [Abstract] [Full-text]
32. A double-blind, dose-response study of losartan in hypertensive children.
    Am J Hypertens, 18(2): 183-90. [Abstract] [Full-text]
33. Insulin sensitivity and endothelial function in hypertension: a comparison of temocapril and candesartan.
    Am J Hypertens, 18(2): 178-82. [Abstract] [Full-text]
34. Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan.
    Am J Hypertens, 18(2): 171-7. [Abstract] [Full-text]
35. In-hospital complications of acute myocardial infarction in hypertensive subjects.
    Am J Hypertens, 18(2): 165-70. [Abstract] [Full-text]
36. Relationship among end-stage renal disease, hypertension, and sleep apnea in nondiabetic dialysis patients.
    Am J Hypertens, 18(2): 152-7. [Abstract] [Full-text]
37. Use of noninvasive hemodynamics in hypertension management.
    Am J Hypertens, 18(2): 87S-91S. [Abstract] [Full-text]
38. Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patients.
    Am J Hypertens, 18(2): 73S-81S. [Abstract] [Full-text]
39. Prognostic value of hemodynamic findings from impedance cardiography in hypertensive stroke.
    Am J Hypertens, 18(2): 65S-72S. [Abstract] [Full-text]
40. Noninvasive hemodynamic profiles in hypertensive subjects.
    Am J Hypertens, 18(2): 51S-59S. [Abstract] [Full-text]
41. Hypertension as a hemodynamic disease: the role of impedance cardiography in diagnostic, prognostic, and therapeutic decision making.
    Am J Hypertens, 18(2): 26S-43S. [Abstract] [Full-text]
42. Hypertension management in type 2 diabetes mellitus: recommendations of the Joint National Committee VII.
    Endocrinol Metab Clin North Am, 34(1): 63-75. [Abstract] [Full-text]
43. Renoprotection with and without blood pressure reduction.
    Kidney Int Suppl. [Abstract] [Full-text]
44. What have we learned from clinical trials on prevention?
    Kidney Int Suppl. [Abstract] [Full-text]
45. Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study.
    Circulation, 111(9): 1121-7. [Abstract] [Full-text]
46. Ventricular structure and function in aged dogs with renal hypertension: a model of experimental diastolic heart failure.
    Circulation, 111(9): 1128-35. [Abstract] [Full-text]
47. Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats.
    Am J Physiol Renal Physiol, 288(4): F810-5. [Abstract] [Full-text]
48. AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity.
    Am J Physiol Renal Physiol, 288(4): F763-70. [Abstract] [Full-text]
49. Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon.
    Am J Physiol Renal Physiol, 288(4): F626-36. [Abstract] [Full-text]
50. Glomerular and tubular damage in normotensive and hypertensive rats.
    Am J Physiol Renal Physiol, 288(4): F665-72. [Abstract] [Full-text]
51. Gender differences in hypertension and kidney disease.
    Med Clin North Am, 89(3): 613-30. [Abstract] [Full-text]
52. Etiology and management of hypertension in chronic kidney disease.
    Med Clin North Am, 89(3): 525-47. [Abstract] [Full-text]
53. Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage.
    Can J Physiol Pharmacol, 83(1): 29-41. [Abstract] [Full-text]
54. The syndromes of low-renin hypertension: "separating the wheat from the chaff".
    Arq Bras Endocrinol Metabol, 48(5): 674-81. [Abstract] [Full-text]
55. Differential cognitive outcomes in the Hypertensive Old People in Edinburgh study.
    J Neurol Sci, 229: 103-7. [Abstract] [Full-text]
56. Effects of renal denervation of the contralateral kidney on blood pressure and sodium and eicosanoid excretion in the chronic phase of two-kidney, one-clip renovascular hypertension in rats.
    Scand J Urol Nephrol, 39(1): 15-20. [Abstract] [Full-text]
57. Effects of lipopolysaccharide on the blood-brain barrier permeability in prolonged nitric oxide blockade-induced hypertensive rats.
    Int J Neurosci, 115(2): 151-68. [Abstract] [Full-text]
58. Recent hypertension trials: implications and controversies.
    J Am Coll Cardiol, 45(6): 813-27. [Abstract] [Full-text]
59. Salt and hypertension: a phylogenetic perspective.
    Diabetes Metab Res Rev, 21(2): 118-31. [Abstract] [Full-text]
60. Beneficial effect of simvastatin and pravastatin treatment on adverse cardiac remodelling and glomeruli loss in spontaneously hypertensive rats.
    Clin Sci (Lond), 108(4): 349-55. [Abstract] [Full-text]
61. Children in South Asia have higher body mass-adjusted blood pressure levels than white children in the United States: a comparative study.
    Circulation, 111(10): 1291-7. [Abstract] [Full-text]
62. General practitioners' approach to hypertension in urban Pakistan: disturbing trends in practice.
    Circulation, 111(10): 1278-83. [Abstract] [Full-text]
63. Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection.
    Cardiovasc Res, 66(1): 170-8. [Abstract] [Full-text]
64. Molecular physiology of urate transport.
    Physiology (Bethesda), 20: 125-33. [Abstract] [Full-text]
65. Domain-specific anger expression and blood pressure in an occupational setting.
    J Psychosom Res, 58(1): 43-9. [Abstract] [Full-text]
66. Hypertension--still an important cause of heart failure?
    J Hum Hypertens, 19(4): 267-75. [Abstract] [Full-text]
67. Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy.
    J Hum Hypertens, 19(4): 301-7. [Abstract] [Full-text]
68. The Ask-Upmark kidney: a curable cause of hypertension in young patients.
    J Hum Hypertens, 19(4): 315-6. [Abstract] [Full-text]
69. Endogenous endothelin attenuates the pressor response to acute environmental stress via the ETA receptor.
    Am J Physiol Heart Circ Physiol, 288(4): H1829-35. [Abstract] [Full-text]
70. Antihypertensive medication adherence and blood pressure control in patients with psychotic disorders compared to persons without psychiatric illness.
    Psychosomatics, 46(2): 135-41. [Abstract] [Full-text]
71. Optimal bedside urinalysis for the detection of proteinuria in hypertensive pregnancy: a study of diagnostic accuracy.
    BJOG, 112(4): 412-7. [Abstract] [Full-text]
72. Decreased plasma levels of nitric oxide metabolites, angiotensin II, and aldosterone in spontaneously hypertensive rats exposed to 5 mT static magnetic field.
    Bioelectromagnetics, 26(3): 161-72. [Abstract] [Full-text]
73. A prospective study of hypertension and risk of uterine leiomyomata.
    Am J Epidemiol, 161(7): 628-38. [Abstract] [Full-text]
74. Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects.
    Am J Cardiol, 95(7): 905-8. [Abstract] [Full-text]
75. Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects.
    Free Radic Biol Med, 38(8): 1032-6. [Abstract] [Full-text]
76. Vascular risk and low serum B12 predict white matter lesions in patients with major depression.
    J Affect Disord, 85(3): 327-32. [Abstract] [Full-text]
77. Acute administration of 17beta-estradiol improves endothelium-dependent vasodilation in postmenopausal women.
    Maturitas, 50(4): 266-74. [Abstract] [Full-text]
78. Inflammation may be a bridge connecting hypertension and atherosclerosis.
    Med Hypotheses, 64(5): 925-9. [Abstract] [Full-text]
79. Assessment of cardiovascular risk factors and their correlation in 28,000 Hungarians.
    Public Health, 119(5): 437-41. [Abstract] [Full-text]
80. Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes.
    Kidney Int, 67(4): 1462-70. [Abstract] [Full-text]
81. Development of diabetic nephropathy in the Milan normotensive strain, but not in the Milan hypertensive strain: possible permissive role of hemodynamics.
    Kidney Int, 67(4): 1440-52. [Abstract] [Full-text]
82. Low-grade albuminuria and the risks of hypertension and blood pressure progression.
    Circulation, 111(11): 1370-6. [Abstract] [Full-text]
83. Simultaneous multiple hypertensive intracerebral haemorrhages.
    Acta Neurochir (Wien), 147(4): 393-9; discussion 399. [Abstract] [Full-text]
84. Renal-portal shunt ameliorates renovascular hypertension in pigs.
    Artif Organs, 29(4): 333-7. [Abstract] [Full-text]
85. Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
    Hypertension, 45(4): 580-5. [Abstract] [Full-text]
86. Is high pulse pressure a marker of preclinical cardiovascular disease?
    Hypertension, 45(4): 575-9. [Abstract] [Full-text]
87. Prevalence, persistence, and clinical significance of masked hypertension in youth.
    Hypertension, 45(4): 493-8. [Abstract] [Full-text]
88. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness.
    Hypertension, 45(4): 505-12. [Abstract] [Full-text]
89. Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.
    Hypertension, 45(4): 530-7. [Abstract] [Full-text]
90. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension.
    Hypertension, 45(4): 705-9. [Abstract] [Full-text]
91. Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension.
    Hypertension, 45(4): 586-91. [Abstract] [Full-text]
92. Components of the metabolic syndrome and carotid atherosclerosis: role of elevated blood pressure.
    Hypertension, 45(4): 597-601. [Abstract] [Full-text]
93. PGC-1alpha Gly482Ser polymorphism associates with hypertension among Danish whites.
    Hypertension, 45(4): 565-70. [Abstract] [Full-text]
94. Persistent sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term morbidity?
    Hypertension, 45(4): 513-21. [Abstract] [Full-text]
95. Management of hypertension in the setting of autonomic failure: a pathophysiological approach.
    Hypertension, 45(4): 469-76. [Abstract] [Full-text]
96. Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus.
    Hypertension, 45(4): 659-65. [Abstract] [Full-text]
97. Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats.
    Hypertension, 45(4): 643-8. [Abstract] [Full-text]
98. Impact of obesity on 24-hour ambulatory blood pressure and hypertension.
    Hypertension, 45(4): 602-7. [Abstract] [Full-text]
99. Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives.
    Hypertension, 45(4): 571-4. [Abstract] [Full-text]
100. Reduced left ventricular functional reserve in hypertensive patients with preserved function at rest.
     Hypertension, 45(4): 619-24. [Abstract] [Full-text]
101. Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway.
     Hypertension, 45(4): 538-44. [Abstract] [Full-text]
102. Combined genealogical, mapping, and expression approaches to identify spontaneously hypertensive rat hypertension candidate genes.
     Hypertension, 45(4): 698-704. [Abstract] [Full-text]
103. Central neuropeptide Y signaling ameliorates N(omega)-nitro-L-arginine methyl ester hypertension in the rat through a Y1 receptor mechanism.
     Hypertension, 45(4): 780-5. [Abstract] [Full-text]
104. Corcoran Lecture. Cardiovascular genomics and oxidative stress.
     Hypertension, 45(4): 636-42. [Abstract] [Full-text]
105. Hyperaldosteronism and hypertension: ethnic differences.
     Hypertension, 45(4): 766-72. [Abstract] [Full-text]
106. Genomic susceptibility loci for brain atrophy in hypertensive sibships from the GENOA study.
     Hypertension, 45(4): 793-8. [Abstract] [Full-text]
107. Fenofibrate prevents the development of angiotensin II-dependent hypertension in mice.
     Hypertension, 45(4): 730-5. [Abstract] [Full-text]
108. Dietary protein source determines the degree of hypertension and renal disease in the Dahl salt-sensitive rat.
     Hypertension, 45(4): 736-41. [Abstract] [Full-text]
109. Renal denervation abolishes hypertension in low-birth-weight offspring from pregnant rats with reduced uterine perfusion.
     Hypertension, 45(4): 754-8. [Abstract] [Full-text]
110. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
     Hypertension, 45(4): 759-65. [Abstract] [Full-text]
111. Hypertension genes are genetic markers for insulin sensitivity and resistance.
     Hypertension, 45(4): 799-803. [Abstract] [Full-text]
112. Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress.
     Hypertension, 45(4): 786-92. [Abstract] [Full-text]
113. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions.
     Hypertension, 45(4): 811-7. [Abstract] [Full-text]
114. Baroreflex regulation of renal sympathetic nerve activity and heart rate in renal wrap hypertensive rats.
     Am J Physiol Regul Integr Comp Physiol, 288(4): R856-62. [Abstract] [Full-text]
115. Recent insights into the interactions between the baroreflex and the kidneys in hypertension.
     Am J Physiol Regul Integr Comp Physiol, 288(4): R828-36. [Abstract] [Full-text]
116. Effects of early perturbation of the renin-angiotensin system on cardiovascular remodeling in spontaneously hypertensive rats.
     Vascul Pharmacol, 42(3): 93-8. [Abstract] [Full-text]
117. Angiotensin II-induced hypertension in mice caused an increase in insulin secretion.
     Vascul Pharmacol, 42(3): 83-92. [Abstract] [Full-text]
118. Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress.
     Am J Physiol Regul Integr Comp Physiol, 288(4): R903-8. [Abstract] [Full-text]
119. Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension.
     Am J Physiol Regul Integr Comp Physiol, 288(4): R1057-62. [Abstract] [Full-text]
120. Cadmium-induced nephropathy in the development of high blood pressure.
     Toxicol Lett, 157(1): 57-68. [Abstract] [Full-text]
121. Nurse-led adherence support in hypertension: a randomized controlled trial.
     Fam Pract, 22(2): 144-51. [Abstract] [Full-text]
122. Non-invasive high-frequency vascular ultrasound elastography.
     Phys Med Biol, 50(7): 1611-28. [Abstract] [Full-text]
123. Angiotensin converting enzyme insertion/deletion polymorphism does not influence postcardiac transplantation hypertension onset or progression.
     J Heart Lung Transplant, 24(4): 406-10. [Abstract] [Full-text]
124. A unifying pathway for essential hypertension.
     Am J Hypertens, 18(3): 431-40. [Abstract] [Full-text]
125. Erectile dysfunction and its influence on quality of life in patients with essential hypertension.
     Am J Hypertens, 18(3): 427-30. [Abstract] [Full-text]
126. Renal norepinephrine spillover during infusion of nonesterified fatty acids.
     Am J Hypertens, 18(3): 422-6. [Abstract] [Full-text]
127. Measuring arteriolar-to-venous ratio in retinal photography of patients with hypertension: development and application of a new semi-automated method.
     Am J Hypertens, 18(3): 417-21. [Abstract] [Full-text]
128. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
     Am J Hypertens, 18(3): 409-16. [Abstract] [Full-text]
129. Association study of calcitonin-receptor-like receptor gene in essential hypertension.
     Am J Hypertens, 18(3): 403-8. [Abstract] [Full-text]
130. Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide.
     Am J Hypertens, 18(3): 398-402. [Abstract] [Full-text]
131. beta(2)-Adrenergic receptor polymorphisms and determinants of cardiovascular risk: the Cardiovascular Health Study.
     Am J Hypertens, 18(3): 392-7. [Abstract] [Full-text]
132. Lower hypertension risk in Mexico City than in San Antonio.
     Am J Hypertens, 18(3): 385-91. [Abstract] [Full-text]
133. Significance of elevated blood pressure and its management on the short-term outcome of patients with acute ischemic stroke.
     Am J Hypertens, 18(3): 379-84. [Abstract] [Full-text]
134. Risk reduction therapy for syndrome X: comparison of several treatments.
     Am J Hypertens, 18(3): 372-8. [Abstract] [Full-text]
135. Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats.
     Am J Hypertens, 18(3): 364-71. [Abstract] [Full-text]
136. The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study.
     Am J Hypertens, 18(3): 358-63. [Abstract] [Full-text]
137. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
     Am J Hypertens, 18(3): 325-9. [Abstract] [Full-text]
138. Vascular abnormalities in asymptomatic, healthy young adult smokers without other major cardiovascular risk factors: the Bogalusa Heart Study.
     Am J Hypertens, 18(3): 319-24. [Abstract] [Full-text]
139. Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients.
     Am J Hypertens, 18(3): 308-18. [Abstract] [Full-text]
140. Nurse administered telephone intervention for blood pressure control: a patient-tailored multifactorial intervention.
     Patient Educ Couns, 57(1): 5-14. [Abstract] [Full-text]
141. 19F NMR measurements of NO production in hypertensive ISIAH and OXYS rats.
     Biochem Biophys Res Commun, 330(2): 367-70. [Abstract] [Full-text]
142. Family history of stroke in patients with transient ischemic attack in relation to hypertension and other intermediate phenotypes.
     Stroke, 36(4): 830-5. [Abstract] [Full-text]

© 2004-2008 Hypertension Research Today. All Rights Reserved.